Mechanism of autophagy activation in exercise-induced anti-diabetic benefits

自噬激活在运动引起的抗糖尿病益处中的机制

基本信息

  • 批准号:
    10522769
  • 负责人:
  • 金额:
    $ 46.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-12 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

Modified Project Summary / Abstract Section This is a renewal application for R01 DK113170 to investigate the role and mechanism of autophagy activation in the regulation of exercise-induced metabolic benefits against type 2 diabetes (T2D). T2D is a sedentarism-associated disease affecting glucose metabolism and a risk factor for other disorders. Physical exercise has been widely recognized to exert beneficial effects against T2D. However, the mechanisms by which exercise elicits systemic metabolic benefits are unclear, which limits the development of therapeutic interventions. Autophagy is an essential intracellular degradation pathway, in which damaged or unnecessary cargos are transported to and broken down in lysosomes. It occurs at a low basal level under normal conditions, and can be induced by stressors such as fasting. We found that exercise is a potent inducer of autophagy, not only in contracting muscle tissues but also systemically in non-contractile tissues such as the liver. The mechanism and metabolic importance of autophagy activation by exercise in non-contractile tissues have never been addressed. Our preliminary data reveal that systemic autophagy activation may be mediated by exercise-induced circulating factors. By proteomic studies we discovered that fibronectin (Fn1), generally considered as an extracellular matrix protein under normal (resting) conditions, is significantly increased in the circulation after acute exercise. Importantly, muscle-specific depletion of fibronectin (FN1[delta]muscle mice) abolishes exercise-induced circulating fibronectin levels, autophagy activation in the liver, and systemic insulin sensitization, suggesting that muscle-secreted fibronectin is an essential regulator of exercise-induced systemic autophagy and metabolic benefits. In addition, knockdown of the fibronectin receptor, α5β1 integrin, abolishes the ability of exercised mouse serum in activating autophagy in cultured cells, further supporting the key role of the fibronectin-α5β1 integrin pathway in exercise-induced autophagy. Based on these data, we propose our overall hypothesis that autophagy activation in non-contractile tissues drives exercise-induced metabolic benefits against T2D, through a fibronectin-α5β1 integrin-IKK-JNK1 pathway. Using a combination of genetic, metabolic, biochemical, and cell biology approaches, we propose two aims: Aim 1 is to determine whether exercise activates autophagy systemically in non-contractile tissues via the fibronectin-α5β1 integrin-IKK-JNK1 pathway; and Aim 2 is to determine whether autophagy activation by the fibronectin-α5β1 integrin-JNK pathway in non-contractile tissues mediates exercise-induced metabolic benefits against T2D. Overall, our studies will establish the physiological importance of exercise-activated autophagy in non-contractile tissues in the prevention of T2D, and will demonstrate the previously uncharacterized function and mechanism of the fibronectin-integrin signaling pathway in regulating muscle-liver communication and whole-body metabolism.
修改的项目摘要 /摘要部分 这是R01 DK113170的续订,用于对2型糖尿病(T2D)的锻炼效果的作用和机制对T2D进行了反对,锻炼者Syst emic代谢有益的机制,其中损坏或不必要的cargos被运送到溶酶体中。仅在肌肉组织中,但在非收缩组织(例如肝脏)中,我们的初步数据可能会通过运动和循环蛋白研究来介导自噬激活。急性运动后正常(静止)下的蛋白质在循环中增加。分泌的纤连蛋白是CTIN受体的特别重新调节蛋白。通过纤连蛋白-IKK-JNK1途径对T2D的益处。并通过非取包组织中的纤连蛋白-α5β1整合素-JNK途径的瞄准,介导运动运动的锻炼 - 总体上对T2D的代谢益处,我们的研究将在非合同组织中建立运动性,并将证明,并将证明在调节肝道和整个体体代谢中,纤连蛋白 - 整合素信号通路的功能和机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Congcong He其他文献

Congcong He的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Congcong He', 18)}}的其他基金

Autophagic regulation of cocaine abuse
可卡因滥用的自噬调节
  • 批准号:
    10838802
  • 财政年份:
    2022
  • 资助金额:
    $ 46.15万
  • 项目类别:
Autophagic regulation of cocaine abuse
可卡因滥用的自噬调节
  • 批准号:
    10503559
  • 财政年份:
    2022
  • 资助金额:
    $ 46.15万
  • 项目类别:
Autophagic regulation of cocaine abuse
可卡因滥用的自噬调节
  • 批准号:
    10682457
  • 财政年份:
    2022
  • 资助金额:
    $ 46.15万
  • 项目类别:
Autophagy-facilitated secretion in metabolic maintenance
自噬促进代谢维持中的分泌
  • 批准号:
    10367132
  • 财政年份:
    2021
  • 资助金额:
    $ 46.15万
  • 项目类别:
Autophagy-facilitated secretion in metabolic maintenance
自噬促进代谢维持中的分泌
  • 批准号:
    10490364
  • 财政年份:
    2021
  • 资助金额:
    $ 46.15万
  • 项目类别:
Autophagy-facilitated secretion in metabolic maintenance
自噬促进代谢维持中的分泌
  • 批准号:
    10665778
  • 财政年份:
    2021
  • 资助金额:
    $ 46.15万
  • 项目类别:
Mechanism of autophagy activation in exercise-induced anti-diabetic benefits
自噬激活在运动引起的抗糖尿病益处中的机制
  • 批准号:
    10704114
  • 财政年份:
    2017
  • 资助金额:
    $ 46.15万
  • 项目类别:
A novel autophagy gene beclin 2 in the prevention of type 2 diabetes and obesity
新型自噬基因 beclin 2 预防 2 型糖尿病和肥胖
  • 批准号:
    8774357
  • 财政年份:
    2014
  • 资助金额:
    $ 46.15万
  • 项目类别:
A novel autophagy gene beclin 2 in the prevention of type 2 diabetes and obesity
新型自噬基因 beclin 2 预防 2 型糖尿病和肥胖
  • 批准号:
    8989093
  • 财政年份:
    2014
  • 资助金额:
    $ 46.15万
  • 项目类别:
A novel autophagy gene beclin 2 in the prevention of type 2 diabetes and obesity
新型自噬基因 beclin 2 预防 2 型糖尿病和肥胖
  • 批准号:
    8538967
  • 财政年份:
    2012
  • 资助金额:
    $ 46.15万
  • 项目类别:

相似国自然基金

SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
  • 批准号:
    82300764
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
  • 批准号:
    82370175
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
  • 批准号:
    82370165
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Phosphatidylinositol 3-Phosphate in the Regulation of Autophagic Membrane Remodeling
磷脂酰肌醇 3-磷酸在自噬膜重塑调节中的作用
  • 批准号:
    10506784
  • 财政年份:
    2022
  • 资助金额:
    $ 46.15万
  • 项目类别:
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
PI3K 抑制预防 B 细胞急性淋巴细胞白血病复发的新用途
  • 批准号:
    10455633
  • 财政年份:
    2021
  • 资助金额:
    $ 46.15万
  • 项目类别:
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
PI3K 抑制预防 B 细胞急性淋巴细胞白血病复发的新用途
  • 批准号:
    10289183
  • 财政年份:
    2021
  • 资助金额:
    $ 46.15万
  • 项目类别:
Neuropilin-2 in Alloimmunity
同种免疫中的 Neuropilin-2
  • 批准号:
    10355442
  • 财政年份:
    2020
  • 资助金额:
    $ 46.15万
  • 项目类别:
The Na/K-ATPase receptor function as a novel therapeutic target in myocardial infarction
Na/K-ATP酶受体作为心肌梗死的新型治疗靶点
  • 批准号:
    9813314
  • 财政年份:
    2019
  • 资助金额:
    $ 46.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了